Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

28/11/2019 Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose 11/01/2018 Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review 01/08/2017 Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data 22/03/2016 Definition and classification of intraoperative complications (CLASSIC): Delphi study and pilot evaluation 10/02/2016 PRISMA harms checklist: improving harms reporting in systematic reviews 11/02/2015 Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study 30/09/2013 Better reporting of harms in randomized trials: an extension of the CONSORT Statement

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More